Valuation : Microba Life Sciences Limited

Market Cap 40.88M 29.52M 25.38M 23.88M 21.79M 40.67M 2.8B 283M 109M 1.43B 111M 108M 4.55B P/E 2027 *
-6.33x
P/E 2028 * -28.5x
Enterprise Value 33.46M 24.16M 20.77M 19.54M 17.84M 33.28M 2.29B 232M 89.59M 1.17B 90.73M 88.75M 3.73B EV / Sales 2027 *
1.7x
EV / Sales 2028 * 1.07x
Free-Float
63.14%
Yield 2027 *
-
Yield 2028 * -
1 day+2.70%
1 week+5.56%
Current month+5.56%
1 month+18.75%
3 months-9.52%
6 months-30.49%
Current year-25.00%
1 week 0.05
Extreme 0.054
0.06
1 month 0.05
Extreme 0.048
0.06
Current year 0.04
Extreme 0.036
0.1
1 year 0.04
Extreme 0.036
0.1
3 years 0.04
Extreme 0.036
0.38
5 years 0.04
Extreme 0.036
0.45
10 years 0.04
Extreme 0.036
0.45
Manager TitleAgeSince
Chief Executive Officer - 2021-06-30
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 2023-12-31
Director TitleAgeSince
Director/Board Member - 2017-01-30
Director/Board Member - -
Chairman - -
Date Insider Type Main position Quantity % Market Cap. Importance
11/19/24 Buy

Chairman

100,000 0.0223%
11/19/24 Buy

Chairman

100,000 0.0223%
11/19/24 Buy

Director

200,000 0.0447%
Change 5-day change 1-year change 3-year change Capi.($)
+2.70%+5.56%-36.67%-82.99% 28.73M
+0.14%+2.39%+96.20%+505.94% 47.31B
-0.38%-0.65%+17.42%+60.10% 26.51B
-0.10%-0.20%-14.78%-37.18% 6.98B
-1.25%-3.70%+1.02%+141.29% 5.8B
+0.56%-1.14%+17.71%+70.72% 3.36B
-0.27%+0.70%-33.96%+1,744.60% 2.56B
+1.81%+0.63%+121.44%+29.21% 2.23B
+10.76%+7.70%+31.70%+45.19% 2.14B
+0.53%-3.18%-14.10%-54.48% 1.82B
Average +1.44%+0.03%+18.60%+242.24% 9.87B
Weighted average by Cap. +0.18%-0.46%+52.66%+312.52%

Financials

2027 *2028 *
Net sales 19.67M 14.21M 12.21M 11.49M 10.49M 19.57M 1.35B 136M 52.67M 688M 53.34M 52.18M 2.19B 31.1M 22.46M 19.31M 18.17M 16.58M 30.94M 2.13B 215M 83.29M 1.09B 84.35M 82.5M 3.46B
Net income -6.8M -4.91M -4.22M -3.97M -3.63M -6.77M -466M -47.07M -18.21M -238M -18.44M -18.04M -757M -1.8M -1.3M -1.12M -1.05M -960K -1.79M -123M -12.46M -4.82M -62.99M -4.88M -4.77M -200M
Net Debt -7.42M -5.36M -4.61M -4.33M -3.96M -7.38M -508M -51.35M -19.87M -260M -20.12M -19.68M -826M -7.56M -5.46M -4.69M -4.42M -4.03M -7.52M -518M -52.33M -20.24M -265M -20.5M -20.05M -842M
Logo Microba Life Sciences Limited
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel.
Employees
-
Date Price Change Volume
26-09-08 A$0.0570 +2.70% 30,231
26-09-07 A$0.0555 +0.91% 1,568
26-09-02 A$0.0550 -1.79% 122,393
26-09-01 A$0.0560 +3.70% 61,983
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0555AUD
Average target price
0.1182AUD
Spread / Average Target
+113.01%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!